GlassScriptPhysician profile
Jared M Salvo
NPI 1992881858
$10,712.84
in general payments reported to CMS, 2019-2025
24 companies · $732 in 2025
The $732 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,659 · 2020: $509 · 2021: $1,134 · 2022: $3,505 · 2023: $843 · 2024: $1,331 · 2025: $732.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,905.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,759.59 | 2019-2025 | S-Icd System Magnet, Farapulse, Lux-Dx Insertable Cardiac Monitor |
| Atricure, INC. | $2,835.15 | 2019-2024 | |
| Abbott Laboratories | $1,947.85 | 2019-2025 | Gallant, Jot Dx, Aveir |
| Biosense Webster, INC. | $1,092.33 | 2019-2025 | Qdot Micro Catheter, Nuvision Ice Catheter, Carto 3 |
| Preventice Services, LLC | $151.37 | 2019-2021 | |
| Medtronic, INC. | $118.53 | 2023-2024 | Pulseselect, Micra, Mycarelink |
| Cvrx, INC. | $112.08 | 2019 | |
| Novartis Pharmaceuticals Corporation | $102.68 | 2023-2025 | |
| Pfizer INC. | $79.31 | 2019-2025 | |
| Amgen INC. | $75.54 | 2019-2022 | |
| Shockwave Medical, INC | $69.45 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Irhythm Technologies, INC. | $57.84 | 2022-2023 | Zio Xt Patch |
| Gilead Sciences, INC. | $56.93 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.66 | 2021-2023 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $34.92 | 2019-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $30.57 | 2025 | |
| Esperion Therapeutics, INC. | $23.44 | 2021 | |
| Novo Nordisk INC | $21.63 | 2025 | |
| Cardiva Medical, INC. | $20.79 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Alnylam Pharmaceuticals INC. | $18.36 | 2019 | |
| Currax Pharmaceuticals LLC | $15.41 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $13.64 | 2024 | Arcalyst |
| Amarin Pharma, INC. | $12.70 | 2019 | |
| Merck Sharp & Dohme LLC | $12.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Salvo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.